Back

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: HDL cholesterol - A moving target Drug therapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Lorenzo Martin Lobo

Education Administration - Argentine Army, Buenos Aires (Argentina)

4 More presentations in this session

Presentation thumbnail
Mechanistic insights into HDL cholesterol - Current insights.
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Slides Video
Presentation thumbnail
Elevated HDL-C is associated with adverse cardiovascular outcomes
Doctor M. Allard-Ratick (Atlanta, US)
Abstract Slides Video
Presentation thumbnail
Serum modified high density lipoprotein levels assessed by a novel assay was associated with coronary artery calcification in an apparently healthy population
Professor T. Okamura (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Next steps in addressing HDL cholesterol clinical practice.
Professor A. Catapano (Milan, IT)

Access the full session

Session thumbnail
HDL cholesterol - A moving target

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources